Correction: Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status.
作者信息
Li Le, Liu Shangyu, Zhang Zhuxin, Zhou Likun, Zhang Zhenhao, Xiong Yulong, Hu Zhao, Yao Yan
机构信息
Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fu Wai Hospital, Beijing, China.
Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
出版信息
Cardiovasc Diabetol. 2024 Dec 6;23(1):435. doi: 10.1186/s12933-024-02529-z.
Abstract
摘要
相似文献
1
Correction: Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status.
Cardiovasc Diabetol. 2024 Dec 6;23(1):435. doi: 10.1186/s12933-024-02529-z.
2
Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status.
Cardiovasc Diabetol. 2023 Aug 24;22(1):223. doi: 10.1186/s12933-023-01932-2.
3
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
J Cardiol. 2023 Sep;82(3):179-185. doi: 10.1016/j.jjcc.2023.05.002. Epub 2023 May 13.
4
Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Ann Transl Med. 2020 Nov;8(22):1505. doi: 10.21037/atm-20-6968.
5
Baseline High-Sensitivity C-Reactive Protein as a Predictor of Adverse Clinical Events in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
Cardiol Rev. 2025;33(3):227-238. doi: 10.1097/CRD.0000000000000604. Epub 2023 Sep 27.
6
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.
Circulation. 2001 Aug 28;104(9):992-7. doi: 10.1161/hc3401.095074.
7
Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI.
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2882-2892. doi: 10.1016/j.jcin.2020.09.024.
8
Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ann Med. 2022 Dec;54(1):1667-1677. doi: 10.1080/07853890.2022.2083671.
9
Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
Rev Esp Cardiol (Engl Ed). 2016 Aug;69(8):746-53. doi: 10.1016/j.rec.2016.04.002. Epub 2016 May 24.
10
The Association Between High-Sensitivity C-Reactive Protein/Albumin Ratio and Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention.
Angiology. 2022 Oct;73(9):818-826. doi: 10.1177/00033197221110715. Epub 2022 Jun 24.
本文引用的文献
1
Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status.
Cardiovasc Diabetol. 2023 Aug 24;22(1):223. doi: 10.1186/s12933-023-01932-2.
Zotero 插件